|
Genentech inc
vc-mmae adcs ![]() Vc Mmae Adcs, supplied by Genentech inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/vc-mmae+adcs/vc+mmae+adcs/pmc06927763-53-8-4 Average 90 stars, based on 1 article reviews
vc-mmae adcs - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Genentech inc
vcmmae adcs ![]() Vcmmae Adcs, supplied by Genentech inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/vc-mmae+adcs/vcmmae+adcs/pm27773754-103-3-3 Average 90 stars, based on 1 article reviews
vcmmae adcs - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Frontage Laboratories
interchain cysteine-linked adcs (igg1 mab-vcmmae) with an average dar of 3.80 ![]() Interchain Cysteine Linked Adcs (Igg1 Mab Vcmmae) With An Average Dar Of 3.80, supplied by Frontage Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/vc-mmae+adcs/interchain+cysteine+linked+adcs++igg1+mab+vcmmae++with+an+average+dar+of+3+80/pm31872274-51-8-19 Average 90 stars, based on 1 article reviews
interchain cysteine-linked adcs (igg1 mab-vcmmae) with an average dar of 3.80 - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
Image Search Results
Journal: mAbs
Article Title: Clinical pharmacology of vc-MMAE antibody–drug conjugates in cancer patients: learning from eight first-in-human Phase 1 studies
doi: 10.1080/19420862.2019.1699768
Figure Lengend Snippet: ADCs, targets, and tumor indications of eight vc-MMAE ADCs included in the analysis.
Article Snippet: Over the past decade,
Techniques:
Journal: mAbs
Article Title: Clinical pharmacology of vc-MMAE antibody–drug conjugates in cancer patients: learning from eight first-in-human Phase 1 studies
doi: 10.1080/19420862.2019.1699768
Figure Lengend Snippet: PK parameters (mean ± SD [%CV]) of acMMAE, total antibody and unconjugated MMAE post the first dose of vc-MMAE ADCs at 2.4 mg/kg (90 min IV infusion).
Article Snippet: Over the past decade,
Techniques: